PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

Treatment of arterial hypertension (AH) despite the large variety of antihypertensive drugs currently remains one of the most urgent problems in modern cardiology. However, the scheme used in clinical practice does not always correspond to existing recommendations, in particular, of the European Soc...

Descrizione completa

Dettagli Bibliografici
Autori principali:	N. A. Morina, O. D. Savkova, E. A. Fedorova, I. L. Tsarev, A. B. Frolkova, A. E. Tsygankova, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
Natura:	Articolo
Lingua:	Russian
Pubblicazione:	Remedium Group LLC 2017-11-01
Serie:	Медицинский совет
Soggetti:	arterial hypertension cardiovascular complications antihypertensive therapy angiotensin converting enzyme inhibitors renin-angiotensin-aldosterone system blockers slow calcium channel blockers
Accesso online:	https://www.med-sovet.pro/jour/article/view/2007

Documenti analoghi

Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients
di: Annina S. Vischer, et al.
Pubblicazione: (2021-03-01)

Role of antihypertensive medicines in prostate cancer: a systematic review
di: Chinonyerem O. Iheanacho, et al.
Pubblicazione: (2024-04-01)

Blood Pressure Control and Antihypertensive Treatment among Hemodialysis Patients—Retrospective Single Center Experience
di: Piotr Skonieczny, et al.
Pubblicazione: (2021-06-01)

Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies
di: Yang Zhao, et al.
Pubblicazione: (2018-01-01)

Mechanisms of food protein-derived antihypertensive peptides other than ACE inhibition
di: Chibuike C. Udenigwe, et al.
Pubblicazione: (2014-05-01)

Prescription pattern and effectiveness of antihypertensive drugs in patients with aortic dissection who underwent surgery
di: Kuang-Ming Liao, et al.
Pubblicazione: (2023-11-01)

Renin-angiotensin-aldosterone system blockers as the main pathogenetic approach of drug nephroprotection
di: N.D. Filipets, et al.
Pubblicazione: (2019-02-01)

Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
di: Jordan Loader, et al.
Pubblicazione: (2022-06-01)

Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic
di: Simon B. Gressens, et al.
Pubblicazione: (2021-02-01)

Renin-angiotensin system blockers and COVID-19
di: Emmanuelle Vidal-Petiot, et al.
Pubblicazione: (2021-06-01)

Angiotensins and rheumatoid arthritis
di: N. M. Savushkina, et al.
Pubblicazione: (2019-01-01)

Association between types of antihypertensive medication and the risk of atrial fibrillation: a nationwide population study
di: JungMin Choi, et al.
Pubblicazione: (2024-05-01)

Association of Cardiovascular Medications With Adverse Outcomes in a Matched Analysis of a National Cohort of Patients With COVID-19
di: Leonard K. Wang, et al.
Pubblicazione: (2023-06-01)

Assessment of Anti-Hypertensive Drug Adherence by Serial Aldosterone-To-Renin Ratio Measurement
di: Fabrizio Buffolo, et al.
Pubblicazione: (2021-05-01)

Prospects of using genetic testing to increase the effectiveness of antihypertensive therapy
di: N. V. Drobotya, et al.
Pubblicazione: (2020-06-01)

Effect of different single and combined antihypertensive drug regimens on the mortality of critical care patients
di: Yipeng Fang, et al.
Pubblicazione: (2024-08-01)

Research Progress on Antihypertensive Effect of Polysaccharide and Its Mechanism
di: Jilong XU, et al.
Pubblicazione: (2023-02-01)

Antihypertensive therapy in patients with arterial hypertension and concomitant diseases in real clinical practice (according to the National Registry of Arterial Hypertension, 2019–2022)
di: Anna V. Aksenova, et al.
Pubblicazione: (2024-10-01)

INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH CLASS OF ANTIHYPERTENSIVE MEDICINE PRODUCTS TO PREFER?
di: S. V. Stolov
Pubblicazione: (2020-12-01)

Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke
di: Konstantinos Tziomalos, et al.
Pubblicazione: (2017-04-01)

Sartans in the treatment of high-risk hypertension: the abilities of candesartan
di: T E Morozova
Pubblicazione: (2013-06-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
di: K. A. Ghyamdzhyan, et al.
Pubblicazione: (2022-12-01)

The renin–angiotensin–aldosterone-system and right heart failure in congenital heart disease
di: Stine Andersen, et al.
Pubblicazione: (2016-06-01)

Effect of ACEi and ARBs vs Non ACEi/ARBs in Hypertension with Respect to Renal Outcomes in COVID-19 Infection: A Retrospective Cohort Study
di: S Ravitej, et al.
Pubblicazione: (2022-11-01)

Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization
di: Hye-Jin Park, et al.
Pubblicazione: (2022-01-01)

Perspectives of using angiotensin receptor antagonists
di: V V Fomin
Pubblicazione: (2009-06-01)

Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network
di: Steven M. Smith, et al.
Pubblicazione: (2023-01-01)

Hypertension, medications, and risk of severe COVID‐19: A Massachusetts community‐based observational study
di: Ann Z. Bauer, et al.
Pubblicazione: (2021-01-01)

Early Rapid Decline in Kidney Function as a Beneficial Sign After Starting Antihypertensive Medication
di: Joachim Beige
Pubblicazione: (2019-06-01)

The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer
di: José A. Carlos-Escalante, et al.
Pubblicazione: (2021-05-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
di: Maksimov M.L., et al.
Pubblicazione: (2017-02-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
di: M L Maksimov, et al.
Pubblicazione: (2017-03-01)

Clinical pharmacogenetics of angiotensin II receptor blockers in Iraq
di: Hany A Al-Hussaniy, et al.
Pubblicazione: (2023-01-01)

A Study of Morphological Changes in Renal Afferent Arterioles Induced by Angiotensin II Type 1 Receptor Blockers in Hypertensive Patients
di: Yohko Nagai, et al.
Pubblicazione: (2020-01-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
di: M L Maksimov
Pubblicazione: (2010-06-01)

The Evolving Role of Calcium Channel Blockers in Hypertension Management: Pharmacological and Clinical Considerations
di: Kamryn E. Jones, et al.
Pubblicazione: (2024-06-01)

Final results of BIRCOV trial (ARB, ACEI, DRi in COVID-19)
di: D.D. Ivanov, et al.
Pubblicazione: (2021-09-01)

Dataset for discovering new hypertension small molecules using machine learning-aided computational fragment-based design
di: Odifentse Mapula-e Lehasa, et al.
Pubblicazione: (2024-08-01)

Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series
di: Mishita Goel, et al.
Pubblicazione: (2020-08-01)

Renin-angiotensin-aldosterone system in climacteric women with arterial hypertension. Antihypertensive therapy features
di: A. E. Bragina, et al.
Pubblicazione: (2005-12-01)